BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:STX-0712 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of STX-0712\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06950034-3036@assetmemo.bio
DTSTAMP:20261121T005838Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:STX-0712: Phase 1 readout est. (NCT06950034)
DESCRIPTION:STX-0712\, phase 1\, Acute Myeloid Leukemia.\nStudy: A Phase 1 
 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CM
 ML and AML)\nEstimated primary completion: 31 December 2026. This is a Cli
 nicalTrials.gov estimate\, not a confirmed readout date\, and it can move.
 \nDrug page: https://assetmemo.bio/drug/stx-0712#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT06950034
URL:https://assetmemo.bio/drug/stx-0712#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
